共查询到4条相似文献,搜索用时 78 毫秒
1.
Giovanni B. Frisoni Annapaola Prestia Paul E. Rasser Matteo Bonetti Paul M. Thompson 《Journal of neurology》2009,256(6):916-924
Progressive brain atrophy is believed to be the Alzheimer’s disease (AD) marker with the greatest evidence for validity. Mapping
the topography of cortical atrophy throughout the stages of severity may allow the neural networks affected to be identified.
Twenty healthy elderly persons (OH, MMSE 29.1 ± 1.0), 11 patients with incipient AD (iAD, 26.5 ± 2.0), 15 with mild AD (miAD,
23.5 ± 2.2), and 15 with moderate AD (moAD, 16.5 ± 2.0) underwent 3D magnetic resonance. Cortical pattern matching analysis
was performed and maps of percent differences in gray matter distribution were computed between the following groups: iAD
versus OH, miAD versus iAD, and moAD versus miAD. Compared to OH, iAD patients exhibited a mean cortical gray matter loss
of 9–20% in areas encompassing the polysynaptic hippocampal pathway (posterior cingulate/retrosplenial and medial temporal
cortex) and subgenual/orbitofrontal cortices, and a less widespread loss of 5–11% in other neocortical areas. Compared to
iAD, miAD featured widespread mean gray matter loss of 14–19% in areas encompassing the direct hippocampal pathway (temporal
pole, temporoparietal association cortex, and dorsal prefrontal cortex), sensorimotor, and visual cortex, with a less marked
loss (7–9%) in the polysynaptic pathway areas. Compared to miAD, only atrophy in the primary sensorimotor cortex was still
relatively marked in moAD, with a mean gray matter loss of 10–11%; the loss in other regions was generally below 10%. These
findings suggest that the polysynaptic hippocampal pathway is affected in iAD, the direct pathway and sensorimotor and visual
networks are affected in moAD, and the sensorimotor network is affected in moAD.
Electronic supplementary material The online version of this article (doi:) contains supplementary material, which is available to authorized users. 相似文献
2.
Functional MRI (fMRI) studies of mild cognitive impairment (MCI) and Alzheimer's disease (AD) have begun to reveal abnormalities in memory circuit function in humans suffering from memory disorders. Since the medial temporal lobe (MTL) memory system is a site of very early pathology in AD, a number of studies, reviewed here, have focused on this region of the brain. By the time individuals are diagnosed clinically with AD dementia, the substantial memory impairments appear to be associated with not only MTL atrophy but also hypoactivation during memory task performance. Prior to dementia, when individuals are beginning to manifest signs and symptoms of memory impairment, the hippocampal formation and other components of the MTL memory system exhibit substantial functional abnormalities during memory task performance. It appears that, early in the course of MCI when memory deficits and hippocampal atrophy are less prominent, there may be hyperactivation of MTL circuits, possibly representing inefficient compensatory activity. Later in the course of MCI, when considerable memory deficits are present, MTL regions are no longer able to activate during attempted learning, as is the case in AD dementia. Recent fMRI data in MCI and AD are beginning to reveal relationships between abnormalities of functional activity in the MTL memory system and in functionally connected brain regions, such as the precuneus. As this work continues to mature, it will likely contribute to our understanding of fundamental memory processes in the human brain and how these are perturbed in memory disorders. We hope these insights will translate into the incorporation of measures of task-related brain function into diagnostic assessment or therapeutic monitoring, such as for use in clinical trials. 相似文献
3.
Xiaojing Long Lijuan Zhang Weiqi Liao Chunxiang Jiang Bensheng Qiu the Alzheimer's Disease Neuroimaging Initiative 《Human brain mapping》2013,34(12):3400-3410
Laterality of human brain varies under healthy aging and diseased conditions. The alterations in hemispheric asymmetry may embed distinct biomarkers linked to the disease dynamics. Statistical parametric mapping based on high‐resolution magnetic resonance imaging (MRI) and image processing techniques have allowed automated characterization of morphological features across the entire brain. In this study, 149 subjects grouped in healthy young, healthy elderly, mild cognitive impairment (MCI), and Alzheimer's disease (AD) were investigated using multivariate analysis for regional cerebral laterality indexed by surface area, curvature index, cortical thickness, and subjacent white matter volume measured on high‐resolution MR images. Asymmetry alteration of MCI and AD were characterized by marked region‐specific reduction, while healthy elderly featured a distinct laterality shift in the limbic system in addition to regional asymmetry loss. Lack of the laterality shift in limbic system and early loss of asymmetry in entorhinal cortex may be biomarkers to identify preclinical AD among other dementia. Multivariate analysis of hemispheric asymmetry may provide information helpful for monitoring the disease progress and improving the management of MCI and AD. Hum Brain Mapp 34:3400–3410, 2013. © 2012 Wiley Periodicals, Inc. 相似文献
4.
Hampel H Teipel SJ Alexander GE Pogarell O Rapoport SI Möller HJ 《Journal of neural transmission (Vienna, Austria : 1996)》2002,109(5-6):837-855
Summary. Neuropathological studies in Alzheimer's disease (AD) indicate specific loss of layer III and V large pyramidal neurons in
association cortex. These neurons give rise to long cortico-cortical connections, projecting through the corpus callosum,
in an anterior-posterior topology.
Based on these findings we hypothesized that regional corpus callosum atrophy may be a potential in vivo marker for neocortical
neuronal loss in AD.
To evaluate this hypothesis, we developed a method to measure cross-sectional area of the corpus callosum and of five corpus
callosum subregions on midsagittal magnetic resonance imaging scans (MRI). In a subsequent series of six experimental studies
using MRI, 18FDG-PET and EEG, we investigated the relation of white matter hyperintensities (WMH) to corpus callosum size and correlated
regional pattern of corpus callosum atrophy with regional cortical metabolic decline as well as intracortical coherencies.
Mean total corpus callosum area was reduced significantly in AD patients compared to healthy age-matched controls, with the
greatest changes in the rostrum and the splenium and relative sparing of the truncus. The regional pattern of corpus callosum
atrophy was independent of WMH load and correlated significantly with pattern of regional metabolic decline measured with
18FDG-PET, the degree of cognitive impairment and regional decline of bilateral intracortical-coherency in EEG in AD patients.
We further found that hippocampus atrophy, as a marker of early allocortical degeneration, was more pronounced than total
corpus callosum atrophy in mild stages of AD. Regional corpus callosum atrophy in mild disease, however, suggested early neocortical
degeneration in AD. In a longitudinal study, AD patients showed significantly greater rates of corpus callosum atrophy than
controls. Rates of atrophy correlated with progression of clinical dementia severity in AD.
Our results indicate that regional corpus callosum atrophy in AD patients represents the loss of callosal efferent neurons
in corresponding regions of the neocortex. As these neurons are a subset of cortico-cortical projecting neurons, region-specific
corpus callosum atrophy may serve as a marker of progressive neocortical disconnection in AD.
In combination with measurement of hippocampal atrophy, assessment of corpus callosum atrophy over time in individual patients
is useful to evaluate effects on brain structure of currently developed drugs, thought to slow or modify AD progression.
Received November 26, 2001; accepted January 8, 2002 相似文献